CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sirtris Pharmaceuticals, Inc. (NASDAQ: SIRT), a biopharmaceutical company focused on discovering and developing small molecule drugs to treat diseases of aging such as Type 2 Diabetes, announced today that it will present two posters at the Federation of American Societies for Experimental Biology (FASEB) Summer Research Conferences from August 4 to August 9, 2007.
